{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:58:05Z","timestamp":1773403085128,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The work of Andrea Gallo"},{"name":"German Federal Ministry of Education and Research","award":["BMBF 01EO1003 and 01EO1503"],"award-info":[{"award-number":["BMBF 01EO1003 and 01EO1503"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The European Society of Cardiology guidelines for the diagnosis and management of acute pulmonary embolism (PE) developed in collaboration with the European Respiratory Society (ERS) has been updated in 2019. Recommendations were added or updated on all stages of the evaluation and management of pulmonary embolism, encompassing diagnosis, early treatment, and long-term management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case summary<\/jats:title><jats:p>We illustrate an exemplary case, assembled for the purposes of this review, of a 70-year-old woman who presented at the emergency department with dyspnoea and thoracic pain. She was diagnosed with intermediate\u2013high-risk acute PE and promptly treated with low molecular weight heparin. After 24\u2009h of stay in intensive care unit, she was transferred to the cardiology department and switched to non-vitamin K-dependent oral anticoagulant apixaban 10\u2009mg b.i.d. for 7\u2009days and then 5\u2009mg b.i.d. After discharge from the hospital 8\u2009days later, she received standard-dose apixaban 5\u2009mg b.i.d. for 6\u2009months; the dose was reduced to 2.5\u2009mg b.i.d. for long-term secondary prevention. During follow-up, investigations for PE sequelae were performed due to persisting dyspnoea.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This exemplary case report puts into context the main novel recommendations from the 2019 ESC Guidelines, including the combination of clinical (pre-test) probability and adjusted D-dimer cut-offs for diagnosis of acute PE, the key role of right ventricular dysfunction in risk stratification, the choice and dosage of oral anticoagulant agents in early and extended anticoagulation, and the identification and management of chronic sequelae in the long-term follow-up.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaa542","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T12:00:47Z","timestamp":1609761647000},"source":"Crossref","is-referenced-by-count":3,"title":["The 2019 European guidelines on pulmonary embolism illustrated with the aid of an exemplary case report"],"prefix":"10.1093","volume":"5","author":[{"given":"Andrea","family":"Gallo","sequence":"first","affiliation":[{"name":"Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Langenbeckstra\u00dfe 1, Building 403, Room 117, 55131 Mainz, Germany"},{"name":"Department of Medicine and Surgery, Research Centre on Thromboembolic Diseases and Antithrombotic Therapies, University of Insubria, Varese, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4466-0724","authenticated-orcid":false,"given":"Luca","family":"Valerio","sequence":"additional","affiliation":[{"name":"Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Langenbeckstra\u00dfe 1, Building 403, Room 117, 55131 Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2618-347X","authenticated-orcid":false,"given":"Stefano","family":"Barco","sequence":"additional","affiliation":[{"name":"Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Langenbeckstra\u00dfe 1, Building 403, Room 117, 55131 Mainz, Germany"},{"name":"Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"2021021009495176600_ytaa542-B1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"2021021009495176600_ytaa542-B2","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"key":"2021021009495176600_ytaa542-B3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-0037-1613830","article-title":"Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer","volume":"83","author":"Wells","year":"2000","journal-title":"Thromb Haemost"},{"key":"2021021009495176600_ytaa542-B4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archinte.161.1.92","article-title":"Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score","volume":"161","author":"Wicki","year":"2001","journal-title":"Arch Intern Med"},{"key":"2021021009495176600_ytaa542-B5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(17)30885-1","article-title":"Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study","volume":"390","author":"van der Hulle","year":"2017","journal-title":"Lancet"},{"key":"2021021009495176600_ytaa542-B6","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1056\/NEJMoa1909159","article-title":"Diagnosis of pulmonary embolism with d-dimer adjusted to clinical probability","volume":"381","author":"Kearon","year":"2019","journal-title":"N Engl J Med"},{"key":"2021021009495176600_ytaa542-B7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1148\/radiol.2272011139","article-title":"Pulmonary embolism: optimization of small pulmonary artery visualization at multi-detector row CT","volume":"227","author":"Patel","year":"2003","journal-title":"Radiology"},{"key":"2021021009495176600_ytaa542-B8","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1378\/chest.13-0157","article-title":"Clinical impact of findings supporting an alternative diagnosis on CT pulmonary angiography in patients with suspected pulmonary embolism","volume":"144","author":"van Es","year":"2013","journal-title":"Chest"},{"key":"2021021009495176600_ytaa542-B9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcmg.2013.11.004","article-title":"Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism","volume":"7","author":"Pruszczyk","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2021021009495176600_ytaa542-B10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjmed.2015.01.023","article-title":"Predictive value of computed tomography in acute pulmonary embolism: systematic review and meta-analysis","volume":"128","author":"Meinel","year":"2015","journal-title":"Am J Med"},{"key":"2021021009495176600_ytaa542-B11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.106.680421","article-title":"Prognostic value of troponins in acute pulmonary embolism: a meta-analysis","volume":"116","author":"Becattini","year":"2007","journal-title":"Circulation"},{"key":"2021021009495176600_ytaa542-B12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1183\/09031936.00088711","article-title":"Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction","volume":"39","author":"Henzler","year":"2012","journal-title":"Eur Respir J"},{"key":"2021021009495176600_ytaa542-B13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/eurheartj\/ehz367","article-title":"Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial","volume":"41","author":"Barco","year":"2020","journal-title":"Eur Heart J"},{"key":"2021021009495176600_ytaa542-B14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/eurheartj\/ehy873","article-title":"Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis","volume":"40","author":"Barco","year":"2019","journal-title":"Eur Heart J"},{"key":"2021021009495176600_ytaa542-B15","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"key":"2021021009495176600_ytaa542-B16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/archinte.1996.00440140067006","article-title":"The effectiveness of implementing the weight-based heparin nomogram as a practice guideline","volume":"156","author":"Raschke","year":"1996","journal-title":"Arch Intern Med"},{"key":"2021021009495176600_ytaa542-B17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"2021021009495176600_ytaa542-B18","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"Buller","year":"2012","journal-title":"N Engl J Med"},{"key":"2021021009495176600_ytaa542-B19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"key":"2021021009495176600_ytaa542-B20","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archinternmed.2010.367","article-title":"Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review","volume":"170","author":"Iorio","year":"2010","journal-title":"Arch Intern Med"},{"key":"2021021009495176600_ytaa542-B21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejvs.2014.05.001","article-title":"Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials","volume":"48","author":"Kakkos","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2021021009495176600_ytaa542-B22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"2021021009495176600_ytaa542-B23","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl J Med"},{"key":"2021021009495176600_ytaa542-B24","doi-asserted-by":"crossref","first-page":"1601792","DOI":"10.1183\/13993003.01792-2016","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature","volume":"49","author":"Ende-Verhaar","year":"2017","journal-title":"Eur Respir J"},{"key":"2021021009495176600_ytaa542-B25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"key":"2021021009495176600_ytaa542-B26","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s00392-018-1405-1","article-title":"Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial","volume":"108","author":"Barco","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"2021021009495176600_ytaa542-B27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000447247","article-title":"Functional characterization of patients with chronic thromboembolic disease","volume":"91","author":"Held","year":"2016","journal-title":"Respiration"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/5\/2\/ytaa542\/36224625\/ytaa542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/5\/2\/ytaa542\/36224625\/ytaa542.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T10:58:21Z","timestamp":1670669901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytaa542\/6061411"}},"subtitle":[],"editor":[{"given":"Tom","family":"De Potter","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Duplyakov","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Dan","family":"Octavian Nistor","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Alexander","family":"Tindale","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Deepti","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaa542","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2021,1,4]]},"article-number":"ytaa542"}}